SuperNus Pharma Raises $35 Million

Supernus Pharmaceuticals Inc., a Rockville, Md.-based developer of CNS products, has raised around $35 million in its second non-dilutive financing round. Last April, it had announced a $75 million transaction secured by royalties generated from partnered products using Supernus technologies. The company in 2006 raised $45 million in venture capital from firms like Abingworth Management, New Enterprise Associates and OrbiMed Advisors.

PEHUB Community

Join the 12503 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

PE HUB News Briefs

RSS Feed Widget

Marketplace

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget